BR9506235A - Compostos enanciométricos únicos uso dos mesmos processos para sua preparação e de(+)-e-(-)-5-carbometoxi-6-metail-2-((3,4-dimetoxi-2-piridinil)metil )1-h-benzimidazol ou seu sal de sódio em suas for mas cristalinas para inibição de secreção de ácido gástrico e para o tratamento de doenças inflamatórias gastrointestinais e preparação farmacêutica - Google Patents

Compostos enanciométricos únicos uso dos mesmos processos para sua preparação e de(+)-e-(-)-5-carbometoxi-6-metail-2-((3,4-dimetoxi-2-piridinil)metil )1-h-benzimidazol ou seu sal de sódio em suas for mas cristalinas para inibição de secreção de ácido gástrico e para o tratamento de doenças inflamatórias gastrointestinais e preparação farmacêutica

Info

Publication number
BR9506235A
BR9506235A BR9506235A BR9506235A BR9506235A BR 9506235 A BR9506235 A BR 9506235A BR 9506235 A BR9506235 A BR 9506235A BR 9506235 A BR9506235 A BR 9506235A BR 9506235 A BR9506235 A BR 9506235A
Authority
BR
Brazil
Prior art keywords
preparation
enanciometric
metail
carbomethoxy
benzimidazole
Prior art date
Application number
BR9506235A
Other languages
English (en)
Inventor
Per Lennart Lindberg
Per Oskar Sverker Von Unge
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of BR9506235A publication Critical patent/BR9506235A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9506235A 1994-05-27 1995-05-11 Compostos enanciométricos únicos uso dos mesmos processos para sua preparação e de(+)-e-(-)-5-carbometoxi-6-metail-2-((3,4-dimetoxi-2-piridinil)metil )1-h-benzimidazol ou seu sal de sódio em suas for mas cristalinas para inibição de secreção de ácido gástrico e para o tratamento de doenças inflamatórias gastrointestinais e preparação farmacêutica BR9506235A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400511 1994-05-27
PCT/SE1995/000519 WO1995032959A1 (en) 1994-05-27 1995-05-11 Novel dialkoxy-pyridinyl-benzimidazole derivatives

Publications (1)

Publication Number Publication Date
BR9506235A true BR9506235A (pt) 1997-08-12

Family

ID=20392945

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9506235A BR9506235A (pt) 1994-05-27 1995-05-11 Compostos enanciométricos únicos uso dos mesmos processos para sua preparação e de(+)-e-(-)-5-carbometoxi-6-metail-2-((3,4-dimetoxi-2-piridinil)metil )1-h-benzimidazol ou seu sal de sódio em suas for mas cristalinas para inibição de secreção de ácido gástrico e para o tratamento de doenças inflamatórias gastrointestinais e preparação farmacêutica

Country Status (18)

Country Link
EP (1) EP0712401A1 (pt)
JP (1) JPH09504557A (pt)
CN (1) CN1128997A (pt)
AU (1) AU2633095A (pt)
BR (1) BR9506235A (pt)
CA (1) CA2166988A1 (pt)
CZ (1) CZ24396A3 (pt)
EE (1) EE9600011A (pt)
FI (1) FI960367A0 (pt)
HU (1) HU9600005D0 (pt)
IL (1) IL113604A0 (pt)
IS (1) IS4321A (pt)
MA (1) MA23563A1 (pt)
NO (1) NO960268D0 (pt)
PL (1) PL312692A1 (pt)
TN (1) TNSN95062A1 (pt)
WO (1) WO1995032959A1 (pt)
ZA (1) ZA954125B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
JP4610086B2 (ja) 1998-11-18 2011-01-12 アストラゼネカ・アクチエボラーグ 改善された化学的方法および医薬処方物
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2667682A1 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
CA2716367C (en) 2008-02-20 2015-05-26 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
AU2009290712A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof
EP2445499A4 (en) 2009-06-25 2013-02-27 Astrazeneca Ab METHOD FOR TREATING A PATIENT WITH RISK OF DEVELOPING A NSAID-ASSOCIATED SPURGE
UA115139C2 (uk) 2011-12-28 2017-09-25 Поузен Інк. Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT62882A (en) * 1990-06-20 1993-06-28 Astra Ab Process for producing dialkoxy pyridylmethyl sulfinyl benzimidazole derivatives and pharmaceutical compositions comprising same
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung

Also Published As

Publication number Publication date
PL312692A1 (en) 1996-05-13
TNSN95062A1 (fr) 1996-02-06
FI960367A (fi) 1996-01-26
NO960268L (no) 1996-01-23
JPH09504557A (ja) 1997-05-06
EE9600011A (et) 1996-04-15
HU9600005D0 (en) 1996-03-28
IS4321A (is) 1996-01-17
ZA954125B (en) 1995-11-27
IL113604A0 (en) 1995-08-31
AU2633095A (en) 1995-12-21
EP0712401A1 (en) 1996-05-22
MA23563A1 (fr) 1995-12-31
WO1995032959A1 (en) 1995-12-07
CN1128997A (zh) 1996-08-14
CA2166988A1 (en) 1995-12-07
FI960367A0 (fi) 1996-01-26
NO960268D0 (no) 1996-01-23
CZ24396A3 (en) 1996-06-12

Similar Documents

Publication Publication Date Title
IT1177553B (it) Composti farmacologicamente attivi per il trattamento di affezioni gastrointestinali e procedimento di preparazione
FR2722984B1 (fr) Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
DE69630479D1 (de) Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
EE04060B1 (et) Heterotsüklilised ühendid maohappesekretsiooni inhibeerimiseks, protsess nende valmistamiseks ja ravimkoostised
BR9506235A (pt) Compostos enanciométricos únicos uso dos mesmos processos para sua preparação e de(+)-e-(-)-5-carbometoxi-6-metail-2-((3,4-dimetoxi-2-piridinil)metil )1-h-benzimidazol ou seu sal de sódio em suas for mas cristalinas para inibição de secreção de ácido gástrico e para o tratamento de doenças inflamatórias gastrointestinais e preparação farmacêutica
MA24437A1 (fr) Procede de la preparation et de la formulation de dihydrate d'eprosartan
BR9708607A (pt) Composto composição farmacéutica utilização de um composto processo para tratamento ou redução do risco de doença inflamatória num paciente e para a preparação de um composto e intermediário químico
FI96601C (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
PT87796A (pt) Process for the preparation of biocide compounds for the treatment of air in systems of air-conditioned
MC1998A1 (fr) Composes pour le traitement des maladies hyperproliferatibes et procede de preparation
BR9610733A (pt) Composto processos para a preparação do mesmo e para o tratamento de um mamífero composição farmacêutica e utilização de um composto
ATE198751T1 (de) Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
MA23663A1 (fr) Procede de preparation de formulations pharmaceutiques
BR9611234A (pt) Composto formulação farmacêutica uso do composto e processos para tratamento de uma dor e para a preparação de compostos
FI963050A0 (fi) Menetelmä klavulaanihapposuolan valmistamiseksi
IL85963A0 (en) Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
FI97951B (fi) Menetelmä kiinteiden oraalisesti käytettävien ifosfamidivalmisteiden valmistamiseksi
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
BR9506234A (pt) Compostos enancioméricos únicos uso dos mesmos processos para a preparação dos mesmos e de sal de sódio de (+)-e(-)-5-fluor-2-((4-ciclopropilmetoxi-2 -prinidinil)meti)sulfinil-1h- benzimidazol em sua s formas cristalinas para o tratamento de doenças inflamatórias gastrointestinais e preparação farmacêutica
PT84996A (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen
TR23828A (tr) Mikrobisid maddeler pirofosforoez asidin mikrobisid etkili tuzlari ve bunlarin imali icin usul
PT87555A (pt) Process for the preparation and isolation of human splein and of pharmaceutical compounds containing it

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law